CellWell record HH-351911
Residual cardiovascular risk beyond LDL-cholesterol control: what remains unaddressed?
Mohammed Taha; Buraq Al-Ghaieb; Muntadher Al-Bulanee
American Journal of Cardiovascular Disease ยท 2026
In plain language
Approximately 70% of cardiovascular events persist despite LDL-C control due to inflammation and metabolic factors addressable by GLP-1 agonists and SGLT2 inhibitors.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-351911
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.